General-practitioner prescribing

doi:10.1016/0140-6736(92)90032-x

The Lancet

1992

DOI: 10.1016/0140-6736(92)90032-x

|View full text |Cite

General-practitioner prescribing

Abstract: DUNLOP (1969) suggested that "Modern drugs are such potent weapons that the responsibility for their safe production and use can no longer be left entirely to the manufacturer and prescriber", and Owen (1976) has suggested economies in general-practitioner prescribing. The increasing potency and expense of modern drugs threatens to erode the established princ¬ iple of clinical autonomy to prescribers (Lancet, 1976 (DHSS, 1975 In addition, the important subject of awareness of unwanted effects of drugs will b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1993

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

References 36 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Use of medicines in general practice.

Skegg¹,

Doll²,

Perry³

1977

BMJ

183

View full text Add to dashboard Cite

SummaryThe prescriptions issued by general practitioners to a population of about 40 000 people were studied. During one year 53 8% of all males and 65 7% of all females had at least one drug dispensed. The proportion receiving medicines increased with age and was higher among females at all ages. Psychotropic drugs were prescribed more often than any other group and accounted for almost one-fifth of all prescriptions. Altogether 9.7% of the males in the population and 210% of the females received at least one psychotropic drug during the year. Among women aged 45-59 33 0% received a psychotropic drug, and 112% were given an antidepressant. Although antimicrobial drugs were prescribed less often than psychotropic drugs, they were given to more people. IntroductionThe prescribing habits of general practitioners have been studied,1-3but there is a dearth of information about the distribution of prescriptions among their patients. In particular, we know little about the proportion of people who are prescribed specific drugs within a given interval of time. Such information was acquired incidentally in the course of an investigation being carried out into methods of monitoring drugs in general practice,4 and we report here the results relating to the use of medicines by about 40 000 people during the 12 months from 1

show abstract

Use of medicines in general practice.

Skegg¹,

Doll²,

Perry³

1977

BMJ

183

View full text Add to dashboard Cite

show abstract

Explaining variations in prescribing costs across England.

Morton‐Jones

Pringle

1993

BMJ

View full text Add to dashboard Cite

Objective-To derive a predictive model for national prescribing behaviour in terms of basic morbidity and demographic factors.Design-24 demographic, morbidity, and practice factors were entered into a multiple regression analysis to determine the net ingredient cost per patient.Setting-The 90 family health service authorities in England for 1989.Results-For net ingredient cost per patient only two demographic factors (numbers of pensioners and the mobility of the registered population measured by list inflation) and two morbidity related factors (standardised morAality ratios and numbers of prepayment certificates issued) significantly contributed to a multiple regression model. This model explained 81% of the variation in net ingredient cost per registered patient between family health services authorities. The model also enabled a weighting factor of 4-6 (95% confidence interval 3-2 to 6.7) to be derived for the net ingredient cost for elderly patients (compared with the existing prescribing unit factor of 3).Conclusions-The model shows that variations in prescribing costs essentially reflect demand. It also suggests that the current prescribing unit value of 3 for patients aged 65 or more underestimates the extra costs ofprescribing for elderly patients.

show abstract

Drug prescribing by GPs in Wales and in England.

Jones¹,

Sweetnam²,

Elwood³

1980

Journal of Epidemiology & Community Health

View full text Add to dashboard Cite

There are several possible explanations for an excess in prescribing costs in Wales. The proportion of subjects in the community who become ill, or who perceive themselves as ill, could be greater than in England. On the other hand, these proportions could be the same, but the relative numbers who treat themselves, perhaps by the direct purchase of medicaments, could be greater in England than in Wales. Of those who perceive themselves as ill, the

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

General-practitioner prescribing

Cited by 4 publications

References 36 publications

Use of medicines in general practice.

Use of medicines in general practice.

Explaining variations in prescribing costs across England.

Drug prescribing by GPs in Wales and in England.

Contact Info

Product

Resources

About